Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant.
Nasilowska-Adamska B, Rzepecki P, Manko J, Czyz A, Markiewicz M, Federowicz I, Tomaszewska A, Piatkowska-Jakubas B, Wrzesien-Kus A, Bieniaszewska M, Duda D, Szydlo R, Halaburda K, Szczepinski A, Lange A, Hellman A, Robak T, Skotnicki A, Jedrzejczak WW, Walewski J, Holowiecki J, Komarnicki M, Dmoszynska A, Warzocha K, Marianska B. Nasilowska-Adamska B, et al. Among authors: holowiecki j. Bone Marrow Transplant. 2007 Nov;40(10):983-8. doi: 10.1038/sj.bmt.1705846. Epub 2007 Sep 10. Bone Marrow Transplant. 2007. PMID: 17846600
Palifermin does not influence the incidence and severity of GvHD nor long-term survival of patients with hematological diseases undergoing HSCT.
Nasilowska-Adamska B, Szydlo R, Rzepecki P, Czyz A, Tomaszewska A, Markiewicz M, Torosian T, Bieniaszewska M, Hellman A, Jedrzejczak WW, Holowiecki J, Komarnicki M, Warzocha K, Marianska B. Nasilowska-Adamska B, et al. Among authors: holowiecki j. Ann Transplant. 2011 Oct-Dec;16(4):47-54. doi: 10.12659/aot.882218. Ann Transplant. 2011. PMID: 22210421 Clinical Trial.
Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
Grosicki S, Holowiecki J, Kuliczkowski K, Skotnicki A, Hellmann A, Kyrcz-Krzemien S, Dmoszynska A, Sułek K, Kloczko J, Jedrzejczak WW, Warzocha K, Zdziarska B, Wierzbowska A, Pluta A, Komarnicki M, Giebel S. Grosicki S, et al. Among authors: holowiecki j. Am J Hematol. 2015 Oct;90(10):904-9. doi: 10.1002/ajh.24113. Am J Hematol. 2015. PMID: 26149802 Free article. Clinical Trial.
HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.
Nowak J, Nestorowicz K, Graczyk-Pol E, Mika-Witkowska R, Rogatko-Koros M, Jaskula E, Koscinska K, Madej S, Tomaszewska A, Nasilowska-Adamska B, Szczepinski A, Halaburda K, Dybko J, Kuliczkowski K, Czerw T, Giebel S, Holowiecki J, Baranska M, Pieczonka A, Wachowiak J, Czyz A, Gil L, Lojko-Dankowska A, Komarnicki M, Bieniaszewska M, Kucharska A, Hellmann A, Gronkowska A, Jedrzejczak WW, Markiewicz M, Koclega A, Kyrcz-Krzemien S, Mielcarek M, Kalwak K, Styczynski J, Wysocki M, Drabko K, Wojcik B, Kowalczyk J, Gozdzik J, Pawliczak D, Gwozdowicz S, Dziopa J, Szlendak U, Witkowska A, Zubala M, Gawron A, Warzocha K, Lange A. Nowak J, et al. Among authors: holowiecki j. Hum Immunol. 2018 Jun;79(6):403-412. doi: 10.1016/j.humimm.2018.03.011. Epub 2018 Mar 29. Hum Immunol. 2018. PMID: 29605688
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.
Czyz J, Hellmann A, Dziadziuszko R, Hansz J, Goździk J, Hołowiecki J, Stella-Hołowiecka B, Kachel Ł, Knopińska-Posłuszny W, Nagler A, Meder J, Walewski J, Lampka E, Sułek K, Sawicki W, Lange A, Forgacz K, Suchnicki K, Pacuszko T, Skotnicki A, Mensah P, Jurczak W, Kuliczkowski K, Wróbel T, Mazur G, Dmoszyńska A, Wach M, Robak T, Warzocha K. Czyz J, et al. Among authors: holowiecki j. Bone Marrow Transplant. 2002 Jul;30(1):29-34. doi: 10.1038/sj.bmt.1703590. Bone Marrow Transplant. 2002. PMID: 12105774
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.
Czyz J, Szydlo R, Knopinska-Posluszny W, Hellmann A, Gozdzik J, Hansz J, Smolewski P, Robak T, Osowiecki M, Walewski J, Avigdor A, Nagler A, Zemelka T, Pawlicki M, Sawicki Z, Wojtukiewicz M, Kachel L, Holowiecki J, Charlinski G, Jedrzejczak WW. Czyz J, et al. Among authors: holowiecki j. Bone Marrow Transplant. 2004 Jun;33(12):1225-9. doi: 10.1038/sj.bmt.1704508. Bone Marrow Transplant. 2004. PMID: 15094747
Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients.
Holowiecki J, Grosicki S, Sadus-Wojciechowska M, Kachel L, Hellmann A, Mital A, Skotnicki AB, Piatkowska-Jakubas B, Jedrzejczak WW, Paluszewska M, Wach M, Marianska B, Wrzesien-Kus A, Krawczyk-Kulis M, Wojnar J. Holowiecki J, et al. Transplant Proc. 2005 Dec;37(10):4482-7. doi: 10.1016/j.transproceed.2005.10.100. Transplant Proc. 2005. PMID: 16387150
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL.
Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N, Hoelzer D, Doubek M, Mayer J, Piatkowska-Jakubas B, Skotnicki AB, Dombret H, Ribera JM, Piccaluga PP, Czerw T, Kyrcz-Krzemien S, Holowiecki J; Study Group for Adult ALL of the European Leukemia Net. Giebel S, et al. Among authors: holowiecki j. Bone Marrow Transplant. 2010 Jun;45(6):1095-101. doi: 10.1038/bmt.2009.308. Epub 2009 Oct 26. Bone Marrow Transplant. 2010. PMID: 19855438
247 results